Title: Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial
Authors: Videler, W J ×
Badia, L
Harvey, R J
Gane, S
Georgalas, C
van der Meulen, F W
Menger, D J
Lehtonen, M T
Toppila-Salmi, S K
Vento, S I
Hytönen, M
Hellings, Peter
Kalogjera, L
Lund, V J
Scadding, G
Mullol, J
Fokkens, W J #
Issue Date: Nov-2011
Publisher: John Wiley & Sons, Inc.
Series Title: Allergy vol:66 issue:11 pages:1457-68
Article number: 10.1111/j.1398-9995.2011.02693.x
Abstract: In persistent chronic rhinosinusitis (CRS), conventional treatment is often insufficient. Long-term, low-dose administration of macrolides has been suggested as a treatment option. The MACS (Macrolides in chronic rhinosinusitis) study is a randomized placebo-controlled trial evaluating the efficacy of azithromycin (AZM) in CRS.
ISSN: 0105-4538
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Research Group Experimental Oto-rhino-laryngology
Laboratory of Clinical Immunology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science